-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Esperion Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to Q3 2025.
- Esperion Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2025 was -9.67 %, a 274% decline year-over-year.
- Esperion Therapeutics, Inc. annual Operating Margin for 2024 was 16.4 %.
- Esperion Therapeutics, Inc. annual Operating Margin for 2023 was -134 %, a 43.8% increase from 2022.
- Esperion Therapeutics, Inc. annual Operating Margin for 2022 was -238 %, a 17.7% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)